This study aims to evaluate the impact of a Transitional Pain Service (TPS) on hospital readmission rates, opioid consumption, and chronic post-surgical pain(CPSP), Despite increasing recognition of the benefits of integrated transitional pain care, there are limited prospective data evaluating its impact on 30-day readmissions, longitudinal opioid use, and CPSP. This protocol will systematically collect prospective patient data to assess these outcomes.
Primary Objective: To compare the 30-day hospital readmission rate in patients seen by to the Transitional Pain Service. Secondary Objectives: 1. To evaluate reduction in opioid use (MME) at 30, 60, 90, 180, and 365 days. 2. To evaluate patient reported outcomes using BPI, CAGE-AID, SOAPP-14, ESAS, PROMIS-29 at 30, 60, 90, 180, and 365 days to assess patient-reported quality of life and pain outcomes longitudinally. 3. To evaluate the incidence of CPSP 4. To assess demographic and clinical predictors of readmission and opioid reduction. 5. Compare outcomes between TPS patients who receive a brief, skills-based mini-CBT group intervention vs. TPS patients who do not receive mini-CBT, including: * Time trends across 30, 60, 90 days, and 6 and 12 months. * Opioid use (daily MME), and proportion achieving ≥30% MME reduction from baseline; * Pain intensity (NRS/10), BPI severity \& interference, PROMIS-29 domains; * beyond 30-day hospital readmission rate
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
400
Participants will receive a brief, skills-based mini-CBT group intervention
UT MD Anderson Cancer Center
Houston, Texas, United States
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Time frame: Through study completion; an average of 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.